SQNM first-quarter 2010 total revenues up 22%: MicroStockProfit.com

Jun 15 2010

MicroStockProfit.com announces an investment report featuring Sequenom Inc. (Nasdaq:SQNM). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

The full report is available at: www.microstockprofit.com/lp/SQNM

Sequenom Inc. (SQNM) is a diagnostic testing and genetics analysis company. The Company is focused on providing products, services, diagnostic testing, applications and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock and other areas of research. Its development and commercialization efforts in various diagnostic areas include non-invasive women's health-related and prenatal diagnostics, age-related macular degeneration diagnostics, oncology, infectious diseases, and other disorders and diseases. On February 27, 2009, the Company acquired certain assets of SensiGen LLC. 

Message Board Search for SQNM: http://www.boardcentral.com/boards/SQNM

In the report, the analyst notes:

"Total revenue for the first quarter of 2010 grew 22% to $10.6 million, compared with $8.7 million for the first quarter of 2009. The increase in revenue was due to higher systems and consumables sales over the same period last year.  

"In order to meet anticipated demand for the LDTs the Company is developing, SQNM plans to open a second CLIA-certified laboratory in its San Diego facility. It is anticipated that this lab will be operational early in the fourth quarter of 2010."